INVESTORS

Recent News

2020 News Release

CANNSUN MEDHEL GROUP PLC STRENGTHENS ITS BOARD AND CREATES A WOMENS HEALTH DIVISION

DUBLIN , IRELAND , July 10, 2020 /EINPresswire.com/ — Cannsun Medhel Group PLC (“Cannsun” or the “Company”), a 103 year old Biopharmaceutical company focused on …

Read More →
2020 News Release

Cannabis operation supports local community in Cape Town to fight unemployment

Original Article can be found on MMJDAILY. After the end of apartheid in South Africa, many industries and companies relocated to places where production costs …

Read More →
2020 News Release

CANNSUN MEDHEL GROUP PLC ANNOUNCES LETTER OF INTENT WITH MALAYSIAN BASED COMPANY FOR PHARMACEUTICAL PRODUCT DISTRIBUTION

ATHENS, GREECE, February 26, 2020 /EINPresswire.com/ — Cannsun Medhel Group PLC (“Cannsun” or the “Company”), is pleased to announce it has entered into a binding …

Read More →
2020 News Release

CANNSUN MEDHEL GROUP PLC STRENGTHENS GREEK MANAGEMENT TEAM WITH ADDITION OF KEY PHARMACEUTICAL PERSONNEL

Combined 70 years of pharmaceutical sales, distribution and product development expertise ATHENS, GREECE February 19, 2020 – Cannsun Medhel Group PLC (“Cannsun” or the “Company“), is pleased …

Read More →
2020 News Release

CANNSUN MEDHEL GROUP PLC ANNOUNCES BUSINESS COMBINATION CREATING PHARMACEUTICAL FOCUSED HOLDING

Creating a rapidly growing pharmaceutical manufacturer and distributor with global reach  ATHENS, GREECE February 11, 2020 – Cannsun Medhel Group PLC (“Cannsun” or the “Company“), a newly …

Read More →
2020 News Release

CANNSUN MEDHEL GROUP PLC ADDS ADDITIONAL PERSONNEL TO OPERATIONS TEAM

ATHENS, GREECE, February 25, 2020 /EINPresswire.com/ — Cannsun Medhel Group PLC (“Cannsun” or the “Company”), is pleased to announce the addition of several key personnel to the …

Read More →

Investor Contact

Greg Bealer
Chief Financial Officer
Tel: +1 780.970.3789
Email: g.bealer@cannsun.com

Rorisang Ntai
Director
Tel: +27 82 575 1144
Email: rorisang@cannsun.com

Sign-up for Updates and Information for Accredited Investors

Scroll to Top